BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31412151)

  • 21. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
    Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
    Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
    Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
    Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
    Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
    Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal Dexamethasone for the Treatment of CMO Associated with Refractory Sclerouveitis.
    Pohlmann D; Winterhalter S; Pleyer U
    Ocul Immunol Inflamm; 2018; 26(1):160-165. PubMed ID: 27438231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.
    Yuksel B; Karti O; Celik O; Kerci SG; Kusbeci T
    Clin Exp Optom; 2018 Jan; 101(1):116-122. PubMed ID: 28922697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
    Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
    Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
    Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
    Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
    Brunner M; Haueter I; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.
    Fonollosa A; Llorenç V; Artaraz J; Jimenez B; Ruiz-Arruza I; Agirrebengoa K; Cordero-Coma M; Costales-Mier F; Adan A
    Retina; 2016 Sep; 36(9):1778-85. PubMed ID: 27183031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone Intravitreal Implant (Ozurdex) in Paediatric Patients with Non-infectious Intermediate Uveitis and Related Cystoid Macular Oedema: Evaluation of Macular Morphology and Function with Six-month Follow-up; a Deeper Role of MfERG?
    Iarossi G; Coppè AM; Catena G; Petroni S; Montes M; Buzzonetti L
    Ocul Immunol Inflamm; 2022 Jan; 30(1):234-240. PubMed ID: 32835577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis.
    Tomkins-Netzer O; Taylor SR; Bar A; Lula A; Yaganti S; Talat L; Lightman S
    Ophthalmology; 2014 Aug; 121(8):1649-54. PubMed ID: 24650556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
    Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
    Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
    Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
    Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
    Ferrini W; Ambresin A
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.